Tetsuo Asaki

783 total citations
14 papers, 658 citations indexed

About

Tetsuo Asaki is a scholar working on Rheumatology, Hematology and Genetics. According to data from OpenAlex, Tetsuo Asaki has authored 14 papers receiving a total of 658 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Rheumatology, 6 papers in Hematology and 5 papers in Genetics. Recurrent topics in Tetsuo Asaki's work include Eosinophilic Disorders and Syndromes (6 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Tetsuo Asaki is often cited by papers focused on Eosinophilic Disorders and Syndromes (6 papers), Chronic Myeloid Leukemia Treatments (6 papers) and Chronic Lymphocytic Leukemia Research (4 papers). Tetsuo Asaki collaborates with scholars based in Japan and Switzerland. Tetsuo Asaki's co-authors include Taisuke Hamamoto, Keiichi Kuwano, Kenji Kuwabara, Tomoko Niwa, Tetsuhiro Yamada, Shinya Kimura, Haruna Naito, Yukiteru Sugiyama, Asami Hashino and Tatsushi Wakayama and has published in prestigious journals such as Blood, Journal of Medicinal Chemistry and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

Tetsuo Asaki

14 papers receiving 634 citations

Peers

Countries citing papers authored by Tetsuo Asaki

Since Specialization

Citations

This map shows the geographic impact of Tetsuo Asaki's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tetsuo Asaki with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tetsuo Asaki more than expected).

Fields of papers citing papers by Tetsuo Asaki

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tetsuo Asaki. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tetsuo Asaki. The network helps show where Tetsuo Asaki may publish in the future.

Co-authorship network of co-authors of Tetsuo Asaki

This figure shows the co-authorship network connecting the top 25 collaborators of Tetsuo Asaki. A scholar is included among the top collaborators of Tetsuo Asaki based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tetsuo Asaki. Tetsuo Asaki is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Selexipag: An Oral and Selective IP Prostacyclin Receptor Agonist for the Treatment of Pulmonary Arterial Hypertension 2015 ·Journal of Medicinal Chemistry ·Tetsuo Asaki, Keiichi Kuwano, Keith Morrison, John Gatfield, Taisuke Hamamoto, Martine Clozel	69
2	Discovery of a novel class of 1,3-dioxane-2-carboxylic acid derivatives as subtype-selective peroxisome proliferator-activated receptor α (PPARα) agonists 2008 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Tetsuo Asaki, Taisuke Hamamoto, Yukiteru Sugiyama, (unknown), Kenji Kuwabara, Kohji Murakami, (unknown)	9
3	Structure–activity studies on diphenylpyrazine derivatives: A novel class of prostacyclin receptor agonists 2007 ·Bioorganic & Medicinal Chemistry ·Tetsuo Asaki, Taisuke Hamamoto, Yukiteru Sugiyama, Keiichi Kuwano, Kenji Kuwabara	45
4	Structure–activity studies on 1,3-dioxane-2-carboxylic acid derivatives, a novel class of subtype-selective peroxisome proliferator-activated receptor α (PPARα) agonists 2007 ·Bioorganic & Medicinal Chemistry ·Tetsuo Asaki, (unknown), Taisuke Hamamoto, Yukiteru Sugiyama, (unknown), Kenji Kuwabara, Kohji Murakami, (unknown)	23
5	Synthesis and evaluation of N-acylsulfonamide and N-acylsulfonylurea prodrugs of a prostacyclin receptor agonist 2007 ·Bioorganic & Medicinal Chemistry ·Akio Nakamura, Tetsuhiro Yamada, Tetsuo Asaki	28
6	Structural factors contributing to the Abl/Lyn dual inhibitory activity of 3-substituted benzamide derivatives 2007 ·Bioorganic & Medicinal Chemistry Letters ·(unknown), Tomohiro Hamasaki, Toshihiko Inoue, Tatsushi Wakayama, (unknown), Haruna Naito, Tetsuo Asaki, (unknown), Tomoko Niwa	26
7	Structure–activity relationship study on the 6-membered heteroaromatic ring system of diphenylpyrazine-type prostacyclin receptor agonists 2007 ·Bioorganic & Medicinal Chemistry Letters ·Tetsuo Asaki, Taisuke Hamamoto, Yukiteru Sugiyama, Keiichi Kuwano, Kenji Kuwabara, Tomoko Niwa	5
8	2-{4-[(5,6-Diphenylpyrazin-2-yl)(isopropyl)amino]butoxy}-N-(methylsulfonyl)acetamide (NS-304), an Orally Available and Long-Acting Prostacyclin Receptor Agonist Prodrug 2007 ·Journal of Pharmacology and Experimental Therapeutics ·Keiichi Kuwano, Asami Hashino, Tetsuo Asaki, Taisuke Hamamoto, Tetsuhiro Yamada, (unknown), Kenji Kuwabara	141
9	NS-187 (INNO-406), a Bcr-Abl/Lyn dual tyrosine kinase inhibitor. 2007 ·PubMed ·Tomoko Niwa, Tetsuo Asaki, Shinya Kimura	17
10	NS-187 (INNO-406), a Bcr-Abl/Lyn Dual Tyrosine Kinase Inhibitor 2007 ·Tomoko Niwa, Tetsuo Asaki, Shinya Kimura	19
11	Design and synthesis of 3-substituted benzamide derivatives as Bcr-Abl kinase inhibitors 2005 ·Bioorganic & Medicinal Chemistry Letters ·Tetsuo Asaki, Yukiteru Sugiyama, Taisuke Hamamoto, (unknown), (unknown), Haruna Naito, Tomoko Niwa	45
12	NS-187, a potent and selective dual Bcr-Abl/Lyn tyrosine kinase inhibitor, is a novel agent for imatinib-resistant leukemia 2005 ·Blood ·Shinya Kimura, Haruna Naito, Hidekazu Segawa, Junya Kuroda, Takeshi Yuasa, Kiyoshi Sato, Asumi Yokota, Yuri Kamitsuji, Eri Kawata, Eishi Ashihara, Yohei Nakaya, Haruna Naruoka, Tatsushi Wakayama, Kimio Nasu, Tetsuo Asaki, Tomoko Niwa, Kazuko Hirabayashi, Taira Maekawa	198
13	A Dual Bcr-Abl/Lyn Tyrosine Kinase Inhibitor, NS-187, Is a Novel Agent for Imatinib-Resistant Leukemia. 2005 ·Blood ·Shinya Kimura, Haruna Naito, Asumi Yokota, Yuri Kamitsuji, Eri Kawata, Eishi Ashihara, Yohei Nakaya, Haruna Naruoka, Tatsushi Wakayama, Tetsuo Asaki, Tomoko Niwa, Kazuko Hirabayashi, Taira Maekawa	2
14	A Novel Selective Peroxisome Proliferator-Activated Receptor α Agonist, 2-Methyl-c-5-[4-[5-methyl-2-(4-methylphenyl)-4-oxazolyl]butyl]-1,3-dioxane-r-2-carboxylic acid (NS-220), Potently Decreases Plasma Triglyceride and Glucose Levels and Modifies Lipoprotein Profiles in KK-Ay Mice 2004 ·Journal of Pharmacology and Experimental Therapeutics ·Kenji Kuwabara, Kohji Murakami, (unknown), (unknown), Tetsuo Asaki, Masatoshi Murai, Junichi Yano	31

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact